Rapid virological response is the most important predictor of sustained virological response across genotypes in patients with chronic hepatitis C virus infection
- 9 December 2010
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 55 (1) , 69-75
- https://doi.org/10.1016/j.jhep.2010.10.032
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Efficacy and Safety of Peginterferon Alfa-2A (40Kd) Plus Ribavirin in Hepatitis C Patients With Advanced Fibrosis and CirrhosisHepatology, 2010
- Peginterferon alfa‐2a (40kDa) and ribavirin: comparable rates of sustained virological response in sub‐sets of older and younger HCV genotype 1 patientsJournal of Viral Hepatitis, 2009
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearanceNature, 2009
- Diagnosis, management, and treatment of hepatitis C: An update # † ‡Hepatology, 2009
- Occult hepatitis C: How convincing are the current data? #Hepatology, 2009
- Peginterferon and Ribavirin Treatment in African American and Caucasian American Patients With Hepatitis C Genotype 1Gastroenterology, 2006
- Peginterferon Alfa-2b and Ribavirin for the Treatment of Chronic Hepatitis C in Blacks and Non-Hispanic WhitesNew England Journal of Medicine, 2004
- Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis CAnnals of Internal Medicine, 2004
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialPublished by Elsevier ,2001